These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30366688)

  • 1. Atypical fractures and molecular environment: What do we know?
    Elniel AR; Giannoudis PV
    Injury; 2018 Nov; 49(11):1953-1958. PubMed ID: 30366688
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on osteoporosis treatment. Should you stay on bisphosphonate drugs long-term?
    Harv Womens Health Watch; 2012 Aug; 19(12):6. PubMed ID: 23033551
    [No Abstract]   [Full Text] [Related]  

  • 3. Fracture risk associated with chronic use of bisphosphonates: evidence today.
    Charopoulos I; Orme S; Giannoudis PV
    Expert Opin Drug Saf; 2011 Jan; 10(1):67-76. PubMed ID: 21121870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the bisphosphonate I'm taking for osteoporosis actually cause a bone fracture?
    Johns Hopkins Med Lett Health After 50; 2011 Oct; 23(8):7. PubMed ID: 22059260
    [No Abstract]   [Full Text] [Related]  

  • 5. Dispelling confusion about de-prescribing bisphosphonates.
    Eisman JA; White CP
    Med J Aust; 2019 Jan; 210(1):17-19. PubMed ID: 30636304
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonates and atypical femoral fractures: a time for reflection.
    Compston JE
    Maturitas; 2010 Jan; 65(1):3-4. PubMed ID: 19932574
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonate-induced fractures: nature strikes back?
    Aspenberg P
    Acta Orthop; 2008 Aug; 79(4):459-60. PubMed ID: 18766476
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral bisphosphonates and atrial fibrillation.
    Majumdar SR
    BMJ; 2008 Apr; 336(7648):784-5. PubMed ID: 18334526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interactions of proton pump inhibitors with oral bisphosphonates and fracture risk].
    Bartl R; von Tresckow E
    Dtsch Med Wochenschr; 2012 Apr; 137(15):804-5. PubMed ID: 22492419
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical femoral fractures and their relation to bisphosphonate use.
    Tripto-Shkolnik L
    Isr Med Assoc J; 2013 Aug; 15(8):447-50. PubMed ID: 24079069
    [No Abstract]   [Full Text] [Related]  

  • 11. [Jaw necrosis following treatment with biphosphonates--the dose is of crucial significance for the risk].
    Langdahl BL; Hitz M; Melsen B; Pinholt EM
    Ugeskr Laeger; 2009 Mar; 171(13):1103; author reply 1103. PubMed ID: 19330957
    [No Abstract]   [Full Text] [Related]  

  • 12. Bisphosphonate drug holidays--when, why and for how long?
    Anagnostis P; Stevenson JC
    Climacteric; 2015; 18 Suppl 2():32-8. PubMed ID: 26507608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
    Pazianas M
    JAMA Intern Med; 2013 Jan; 173(1):79-80. PubMed ID: 23318593
    [No Abstract]   [Full Text] [Related]  

  • 14. New annual osteoporosis drug reduces risk of death, future fractures. Infused dose is more convenient for patients, enhances overall quality of life.
    Duke Med Health News; 2007 Dec; 13(12):8. PubMed ID: 18286732
    [No Abstract]   [Full Text] [Related]  

  • 15. What to make of the new warning on bisphosphonates. Officials acknowledge a connection between the most popular bone drugs and rare thigh fractures.
    Harv Womens Health Watch; 2010 Dec; 18(4):6-7. PubMed ID: 21268797
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ].
    Mashiba T
    Clin Calcium; 2012 Jun; 22(6):914-8. PubMed ID: 22653033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate drug holidays: we reap what we sow.
    Silverman SL; Adachi JD; Dennison E;
    Osteoporos Int; 2016 Mar; 27(3):849-852. PubMed ID: 26667246
    [No Abstract]   [Full Text] [Related]  

  • 18. Controversies in osteoporosis management: concerns about bisphosphonates and when are "drug holidays" required?
    McClung M
    Clin Obstet Gynecol; 2013 Dec; 56(4):743-8. PubMed ID: 24177063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In brief: duration of use of bisphosphonates.
    Med Lett Drugs Ther; 2011 Oct; 53(1374):77. PubMed ID: 21959355
    [No Abstract]   [Full Text] [Related]  

  • 20. The biology of fracture healing in osteoporosis and in the presence of anti-osteoporotic drugs.
    Hak DJ
    Injury; 2018 Aug; 49(8):1461-1465. PubMed ID: 29709376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.